Clinical Trial Update: Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children [Phase 2]

View source ↗

Summary

Phase 2 trial reported safety and immunogenicity of Takeda's tetravalent dengue vaccine (TDV) in healthy children; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• TDV (Takeda dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 2 | Status: COMPLETED | Results posted: 2021-04-26